Refine your search
145 trials found
Recruiting
Not yet recruiting
Recruiting
NCT05995964
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Atopic Dermatitis
Male or Female
18+ years
96study location(s)
Recruiting
NCT06616194
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Male or Female
12 - 17 years
70study location(s)
Recruiting
NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Male or Female
6 - 17 years
94study location(s)
Recruiting
NCT06679140
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Male or Female
12+ years
90study location(s)
Recruiting
NCT06462235
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
Gram-negative Bacterial Infection
Male or Female
Up to 39 weeks
19study location(s)
Recruiting
NCT06760637
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Male or Female
18+ years
255study location(s)
Recruiting
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Metastatic Castration-Resistant Prostate Cancer
Males
18+ years
186study location(s)
Recruiting
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Male or Female
18+ years
389study location(s)
Recruiting
NCT06977581
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Male or Female
18 - 70 years
16study location(s)
Recruiting
NCT06758401
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Male or Female
18+ years
7study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Recruiting
Not yet recruiting
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.